Global (United States, European Union and China) PCR Technologies

PCR Technologies Comprehensive Study by Type (Instruments, Reagents and consumables, Software and services), Application (Genetic sequencing, Genotyping, Nucleic acid detection, Nucleic acid synthesis, Standard validation/verification, Diagnostic Applications, Industrial Applications, Other Applications), Technology Type Name (Real-Time PCR (quantitative PCR or qPCR), Reverse-Transcriptase (RT-PCR), Multiplex PCR, Nested PCR, High Fidelity PCR, Fast PCR, Hot Start PCR, GC-Rich PCR, Long-range PCR, Arbitrary Primed PCR), End User Name (Research Laboratories, Reference Laboratories, Clinical Diagnostic Laboratories, Forensic Laboratories, Academic Institutes, Hospitals, Pharmaceutical Companies, Biotechnology Industries) Players and Region - Global Market Outlook to 2026

PCR Technologies Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
PCR Technologies Market Scope
PCR stands for Polymerase Chain Response is a sub-atomic diagnostics method utilized for the intensification of DNA. In other words, it is a widely used method to make millions to billions of complete or partial copies of a particular DNA sample. In this technique, a huge number of duplicates of DNA are made in a brief-term subsequent to going through patterns of responses constrained by changes in the temperature through a warm cycler. PCR permits scientists to intensify a limited quantity of DNA into a lot bigger amount which makes it simpler for them to examine the hereditary example in research centers. This method is usually utilized in research labs, medical clinics, and centers for testing the hereditary material or recognizing any microbial microorganism.

The leading players in the market, in order to develop advanced technology products to avail competitive advantage, focusing on the research and development. To make strong product portfolios and manufacturing capacities, players in the market are engaging in different collaborations, partnerships, and acquisitions. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global PCR Technologies market throughout the predicted period.

Fisher Scientific, Inc. (United States), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France), Fluidigm Corporation (United States), Danaher Corporation (United States) and Abbott Laboratories (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Merck KGaA (Germany), Becton Dickinson and Company (United States), Promega Corporation (United States), Eppendorf AG (Germany) and Analytik Jena AG (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global PCR Technologies market by Type (Instruments, Reagents and consumables and Software and services), by Application (Genetic sequencing, Genotyping, Nucleic acid detection, Nucleic acid synthesis, Standard validation/verification, Diagnostic Applications, Industrial Applications and Other Applications) and Region with country level break-up.

On the basis of geography, the market of PCR Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 5 March 2021 – Roche a global pioneer in pharmaceuticals & diagnostics and GenMark Diagnostics a leading provider of multiplex molecular diagnostic solutions was entered into a merger agreement. Acquiring GenMark Diagnostics will broaden Roche’s molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases.
On 17 March 2021, Roche a global pioneer in pharmaceuticals & diagnostics launched Cobas pure integrated solutions in countries accepting the CE mark. With a combination of three technologies on a single platform, this new compact analyzer assisting to simplify daily laboratories operations with limited space and resources. Therefore, this technology solution focuses on the automation of manual tasks that help in improving the productivity of lab personnel and supporting quick clinical decision-making.
World Health Organization (WHO), governing territory is United Nations, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends. and The European Agency for the Evaluation of Medicinal Products (EMA), governing territory is Europe, make rules and regulations and evaluation of medicines for human use

Market Trend
  • Increase in the diagnostic tests of virus in the suspected population due to Covid-19
  • Increase availability of genetic and genomic information is on rising

Market Drivers
  • Advancement in medical technologies in the healthcare industry
  • Increase diagnosis of major infectious diseases and genetic disorders
  • The rise in demand for clinical diagnosis for early detection of diseases
  • Advancements in PCR technologies and Drug development technologies

Opportunities
  • Rising incidence of infectious and chronic diseases in developing countries growing market penetration
  • Growing healthcare infrastructure in emerging countries

Restraints
  • Higher cost of PCR instruments for clinical testing
  • Lack of skilled researchers and technicians who can operate the device properly

Challenges
  • The use of PCR techniques is unregulated globally due to a non-uniform consensus


Key Target Audience
Service Providers, Industry Association, Government Regulatory Bodies, Private Research Organization and Government Research Organization

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Reagents and consumables
  • Software and services
By Application
  • Genetic sequencing
  • Genotyping
  • Nucleic acid detection
  • Nucleic acid synthesis
  • Standard validation/verification
  • Diagnostic Applications
  • Industrial Applications
  • Other Applications
By Technology Type Name
  • Real-Time PCR (quantitative PCR or qPCR)
  • Reverse-Transcriptase (RT-PCR)
  • Multiplex PCR
  • Nested PCR
  • High Fidelity PCR
  • Fast PCR
  • Hot Start PCR
  • GC-Rich PCR
  • Long-range PCR
  • Arbitrary Primed PCR

By End User Name
  • Research Laboratories
  • Reference Laboratories
  • Clinical Diagnostic Laboratories
  • Forensic Laboratories
  • Academic Institutes
  • Hospitals
  • Pharmaceutical Companies
  • Biotechnology Industries

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Advancement in medical technologies in the healthcare industry
      • 3.2.2. Increase diagnosis of major infectious diseases and genetic disorders
      • 3.2.3. The rise in demand for clinical diagnosis for early detection of diseases
      • 3.2.4. Advancements in PCR technologies and Drug development technologies
    • 3.3. Market Challenges
      • 3.3.1. The use of PCR techniques is unregulated globally due to a non-uniform consensus
    • 3.4. Market Trends
      • 3.4.1. Increase in the diagnostic tests of virus in the suspected population due to Covid-19
      • 3.4.2. Increase availability of genetic and genomic information is on rising
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global PCR Technologies, by Type, Application, Technology Type Name, End User Name and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global PCR Technologies (Value)
      • 5.2.1. Global PCR Technologies by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents and consumables
        • 5.2.1.3. Software and services
      • 5.2.2. Global PCR Technologies by: Application (Value)
        • 5.2.2.1. Genetic sequencing
        • 5.2.2.2. Genotyping
        • 5.2.2.3. Nucleic acid detection
        • 5.2.2.4. Nucleic acid synthesis
        • 5.2.2.5. Standard validation/verification
        • 5.2.2.6. Diagnostic Applications
        • 5.2.2.7. Industrial Applications
        • 5.2.2.8. Other Applications
      • 5.2.3. Global PCR Technologies by: Technology Type Name (Value)
        • 5.2.3.1. Real-Time PCR (quantitative PCR or qPCR)
        • 5.2.3.2. Reverse-Transcriptase (RT-PCR)
        • 5.2.3.3. Multiplex PCR
        • 5.2.3.4. Nested PCR
        • 5.2.3.5. High Fidelity PCR
        • 5.2.3.6. Fast PCR
        • 5.2.3.7. Hot Start PCR
        • 5.2.3.8. GC-Rich PCR
        • 5.2.3.9. Long-range PCR
        • 5.2.3.10. Arbitrary Primed PCR
      • 5.2.4. Global PCR Technologies by: End User Name (Value)
        • 5.2.4.1. Research Laboratories
        • 5.2.4.2. Reference Laboratories
        • 5.2.4.3. Clinical Diagnostic Laboratories
        • 5.2.4.4. Forensic Laboratories
        • 5.2.4.5. Academic Institutes
        • 5.2.4.6. Hospitals
        • 5.2.4.7. Pharmaceutical Companies
        • 5.2.4.8. Biotechnology Industries
      • 5.2.5. Global PCR Technologies Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global PCR Technologies (Price)
      • 5.3.1. Global PCR Technologies by: Type (Price)
  • 6. PCR Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffman-La Roche Ltd. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. QIAGEN N.V. (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Takara Bio, Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMérieux S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fluidigm Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danaher Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global PCR Technologies Sale, by Type, Application, Technology Type Name, End User Name and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global PCR Technologies (Value)
      • 7.2.1. Global PCR Technologies by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents and consumables
        • 7.2.1.3. Software and services
      • 7.2.2. Global PCR Technologies by: Application (Value)
        • 7.2.2.1. Genetic sequencing
        • 7.2.2.2. Genotyping
        • 7.2.2.3. Nucleic acid detection
        • 7.2.2.4. Nucleic acid synthesis
        • 7.2.2.5. Standard validation/verification
        • 7.2.2.6. Diagnostic Applications
        • 7.2.2.7. Industrial Applications
        • 7.2.2.8. Other Applications
      • 7.2.3. Global PCR Technologies by: Technology Type Name (Value)
        • 7.2.3.1. Real-Time PCR (quantitative PCR or qPCR)
        • 7.2.3.2. Reverse-Transcriptase (RT-PCR)
        • 7.2.3.3. Multiplex PCR
        • 7.2.3.4. Nested PCR
        • 7.2.3.5. High Fidelity PCR
        • 7.2.3.6. Fast PCR
        • 7.2.3.7. Hot Start PCR
        • 7.2.3.8. GC-Rich PCR
        • 7.2.3.9. Long-range PCR
        • 7.2.3.10. Arbitrary Primed PCR
      • 7.2.4. Global PCR Technologies by: End User Name (Value)
        • 7.2.4.1. Research Laboratories
        • 7.2.4.2. Reference Laboratories
        • 7.2.4.3. Clinical Diagnostic Laboratories
        • 7.2.4.4. Forensic Laboratories
        • 7.2.4.5. Academic Institutes
        • 7.2.4.6. Hospitals
        • 7.2.4.7. Pharmaceutical Companies
        • 7.2.4.8. Biotechnology Industries
      • 7.2.5. Global PCR Technologies Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global PCR Technologies (Price)
      • 7.3.1. Global PCR Technologies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. PCR Technologies: by Type(USD Million)
  • Table 2. PCR Technologies Instruments , by Region USD Million (2015-2020)
  • Table 3. PCR Technologies Reagents and consumables , by Region USD Million (2015-2020)
  • Table 4. PCR Technologies Software and services , by Region USD Million (2015-2020)
  • Table 5. PCR Technologies: by Application(USD Million)
  • Table 6. PCR Technologies Genetic sequencing , by Region USD Million (2015-2020)
  • Table 7. PCR Technologies Genotyping , by Region USD Million (2015-2020)
  • Table 8. PCR Technologies Nucleic acid detection , by Region USD Million (2015-2020)
  • Table 9. PCR Technologies Nucleic acid synthesis , by Region USD Million (2015-2020)
  • Table 10. PCR Technologies Standard validation/verification , by Region USD Million (2015-2020)
  • Table 11. PCR Technologies Diagnostic Applications , by Region USD Million (2015-2020)
  • Table 12. PCR Technologies Industrial Applications , by Region USD Million (2015-2020)
  • Table 13. PCR Technologies Other Applications , by Region USD Million (2015-2020)
  • Table 14. PCR Technologies: by Technology Type Name(USD Million)
  • Table 15. PCR Technologies Real-Time PCR (quantitative PCR or qPCR) , by Region USD Million (2015-2020)
  • Table 16. PCR Technologies Reverse-Transcriptase (RT-PCR) , by Region USD Million (2015-2020)
  • Table 17. PCR Technologies Multiplex PCR , by Region USD Million (2015-2020)
  • Table 18. PCR Technologies Nested PCR , by Region USD Million (2015-2020)
  • Table 19. PCR Technologies High Fidelity PCR , by Region USD Million (2015-2020)
  • Table 20. PCR Technologies Fast PCR , by Region USD Million (2015-2020)
  • Table 21. PCR Technologies Hot Start PCR , by Region USD Million (2015-2020)
  • Table 22. PCR Technologies GC-Rich PCR , by Region USD Million (2015-2020)
  • Table 23. PCR Technologies Long-range PCR , by Region USD Million (2015-2020)
  • Table 24. PCR Technologies Arbitrary Primed PCR , by Region USD Million (2015-2020)
  • Table 25. PCR Technologies: by End User Name(USD Million)
  • Table 26. PCR Technologies Research Laboratories , by Region USD Million (2015-2020)
  • Table 27. PCR Technologies Reference Laboratories , by Region USD Million (2015-2020)
  • Table 28. PCR Technologies Clinical Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 29. PCR Technologies Forensic Laboratories , by Region USD Million (2015-2020)
  • Table 30. PCR Technologies Academic Institutes , by Region USD Million (2015-2020)
  • Table 31. PCR Technologies Hospitals , by Region USD Million (2015-2020)
  • Table 32. PCR Technologies Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 33. PCR Technologies Biotechnology Industries , by Region USD Million (2015-2020)
  • Table 34. South America PCR Technologies, by Country USD Million (2015-2020)
  • Table 35. South America PCR Technologies, by Type USD Million (2015-2020)
  • Table 36. South America PCR Technologies, by Application USD Million (2015-2020)
  • Table 37. South America PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 38. South America PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 39. Brazil PCR Technologies, by Type USD Million (2015-2020)
  • Table 40. Brazil PCR Technologies, by Application USD Million (2015-2020)
  • Table 41. Brazil PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 42. Brazil PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 43. Argentina PCR Technologies, by Type USD Million (2015-2020)
  • Table 44. Argentina PCR Technologies, by Application USD Million (2015-2020)
  • Table 45. Argentina PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 46. Argentina PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 47. Rest of South America PCR Technologies, by Type USD Million (2015-2020)
  • Table 48. Rest of South America PCR Technologies, by Application USD Million (2015-2020)
  • Table 49. Rest of South America PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 50. Rest of South America PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 51. Asia Pacific PCR Technologies, by Country USD Million (2015-2020)
  • Table 52. Asia Pacific PCR Technologies, by Type USD Million (2015-2020)
  • Table 53. Asia Pacific PCR Technologies, by Application USD Million (2015-2020)
  • Table 54. Asia Pacific PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 55. Asia Pacific PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 56. China PCR Technologies, by Type USD Million (2015-2020)
  • Table 57. China PCR Technologies, by Application USD Million (2015-2020)
  • Table 58. China PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 59. China PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 60. Japan PCR Technologies, by Type USD Million (2015-2020)
  • Table 61. Japan PCR Technologies, by Application USD Million (2015-2020)
  • Table 62. Japan PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 63. Japan PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 64. India PCR Technologies, by Type USD Million (2015-2020)
  • Table 65. India PCR Technologies, by Application USD Million (2015-2020)
  • Table 66. India PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 67. India PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 68. South Korea PCR Technologies, by Type USD Million (2015-2020)
  • Table 69. South Korea PCR Technologies, by Application USD Million (2015-2020)
  • Table 70. South Korea PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 71. South Korea PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 72. Australia PCR Technologies, by Type USD Million (2015-2020)
  • Table 73. Australia PCR Technologies, by Application USD Million (2015-2020)
  • Table 74. Australia PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 75. Australia PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific PCR Technologies, by Type USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific PCR Technologies, by Application USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 80. Europe PCR Technologies, by Country USD Million (2015-2020)
  • Table 81. Europe PCR Technologies, by Type USD Million (2015-2020)
  • Table 82. Europe PCR Technologies, by Application USD Million (2015-2020)
  • Table 83. Europe PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 84. Europe PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 85. Germany PCR Technologies, by Type USD Million (2015-2020)
  • Table 86. Germany PCR Technologies, by Application USD Million (2015-2020)
  • Table 87. Germany PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 88. Germany PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 89. France PCR Technologies, by Type USD Million (2015-2020)
  • Table 90. France PCR Technologies, by Application USD Million (2015-2020)
  • Table 91. France PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 92. France PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 93. Italy PCR Technologies, by Type USD Million (2015-2020)
  • Table 94. Italy PCR Technologies, by Application USD Million (2015-2020)
  • Table 95. Italy PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 96. Italy PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 97. United Kingdom PCR Technologies, by Type USD Million (2015-2020)
  • Table 98. United Kingdom PCR Technologies, by Application USD Million (2015-2020)
  • Table 99. United Kingdom PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 100. United Kingdom PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 101. Netherlands PCR Technologies, by Type USD Million (2015-2020)
  • Table 102. Netherlands PCR Technologies, by Application USD Million (2015-2020)
  • Table 103. Netherlands PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 104. Netherlands PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 105. Rest of Europe PCR Technologies, by Type USD Million (2015-2020)
  • Table 106. Rest of Europe PCR Technologies, by Application USD Million (2015-2020)
  • Table 107. Rest of Europe PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 108. Rest of Europe PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 109. MEA PCR Technologies, by Country USD Million (2015-2020)
  • Table 110. MEA PCR Technologies, by Type USD Million (2015-2020)
  • Table 111. MEA PCR Technologies, by Application USD Million (2015-2020)
  • Table 112. MEA PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 113. MEA PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 114. Middle East PCR Technologies, by Type USD Million (2015-2020)
  • Table 115. Middle East PCR Technologies, by Application USD Million (2015-2020)
  • Table 116. Middle East PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 117. Middle East PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 118. Africa PCR Technologies, by Type USD Million (2015-2020)
  • Table 119. Africa PCR Technologies, by Application USD Million (2015-2020)
  • Table 120. Africa PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 121. Africa PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 122. North America PCR Technologies, by Country USD Million (2015-2020)
  • Table 123. North America PCR Technologies, by Type USD Million (2015-2020)
  • Table 124. North America PCR Technologies, by Application USD Million (2015-2020)
  • Table 125. North America PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 126. North America PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 127. United States PCR Technologies, by Type USD Million (2015-2020)
  • Table 128. United States PCR Technologies, by Application USD Million (2015-2020)
  • Table 129. United States PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 130. United States PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 131. Canada PCR Technologies, by Type USD Million (2015-2020)
  • Table 132. Canada PCR Technologies, by Application USD Million (2015-2020)
  • Table 133. Canada PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 134. Canada PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 135. Mexico PCR Technologies, by Type USD Million (2015-2020)
  • Table 136. Mexico PCR Technologies, by Application USD Million (2015-2020)
  • Table 137. Mexico PCR Technologies, by Technology Type Name USD Million (2015-2020)
  • Table 138. Mexico PCR Technologies, by End User Name USD Million (2015-2020)
  • Table 139. PCR Technologies: by Type(USD/Units)
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. PCR Technologies: by Type(USD Million)
  • Table 151. PCR Technologies Instruments , by Region USD Million (2021-2026)
  • Table 152. PCR Technologies Reagents and consumables , by Region USD Million (2021-2026)
  • Table 153. PCR Technologies Software and services , by Region USD Million (2021-2026)
  • Table 154. PCR Technologies: by Application(USD Million)
  • Table 155. PCR Technologies Genetic sequencing , by Region USD Million (2021-2026)
  • Table 156. PCR Technologies Genotyping , by Region USD Million (2021-2026)
  • Table 157. PCR Technologies Nucleic acid detection , by Region USD Million (2021-2026)
  • Table 158. PCR Technologies Nucleic acid synthesis , by Region USD Million (2021-2026)
  • Table 159. PCR Technologies Standard validation/verification , by Region USD Million (2021-2026)
  • Table 160. PCR Technologies Diagnostic Applications , by Region USD Million (2021-2026)
  • Table 161. PCR Technologies Industrial Applications , by Region USD Million (2021-2026)
  • Table 162. PCR Technologies Other Applications , by Region USD Million (2021-2026)
  • Table 163. PCR Technologies: by Technology Type Name(USD Million)
  • Table 164. PCR Technologies Real-Time PCR (quantitative PCR or qPCR) , by Region USD Million (2021-2026)
  • Table 165. PCR Technologies Reverse-Transcriptase (RT-PCR) , by Region USD Million (2021-2026)
  • Table 166. PCR Technologies Multiplex PCR , by Region USD Million (2021-2026)
  • Table 167. PCR Technologies Nested PCR , by Region USD Million (2021-2026)
  • Table 168. PCR Technologies High Fidelity PCR , by Region USD Million (2021-2026)
  • Table 169. PCR Technologies Fast PCR , by Region USD Million (2021-2026)
  • Table 170. PCR Technologies Hot Start PCR , by Region USD Million (2021-2026)
  • Table 171. PCR Technologies GC-Rich PCR , by Region USD Million (2021-2026)
  • Table 172. PCR Technologies Long-range PCR , by Region USD Million (2021-2026)
  • Table 173. PCR Technologies Arbitrary Primed PCR , by Region USD Million (2021-2026)
  • Table 174. PCR Technologies: by End User Name(USD Million)
  • Table 175. PCR Technologies Research Laboratories , by Region USD Million (2021-2026)
  • Table 176. PCR Technologies Reference Laboratories , by Region USD Million (2021-2026)
  • Table 177. PCR Technologies Clinical Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 178. PCR Technologies Forensic Laboratories , by Region USD Million (2021-2026)
  • Table 179. PCR Technologies Academic Institutes , by Region USD Million (2021-2026)
  • Table 180. PCR Technologies Hospitals , by Region USD Million (2021-2026)
  • Table 181. PCR Technologies Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 182. PCR Technologies Biotechnology Industries , by Region USD Million (2021-2026)
  • Table 183. South America PCR Technologies, by Country USD Million (2021-2026)
  • Table 184. South America PCR Technologies, by Type USD Million (2021-2026)
  • Table 185. South America PCR Technologies, by Application USD Million (2021-2026)
  • Table 186. South America PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 187. South America PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 188. Brazil PCR Technologies, by Type USD Million (2021-2026)
  • Table 189. Brazil PCR Technologies, by Application USD Million (2021-2026)
  • Table 190. Brazil PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 191. Brazil PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 192. Argentina PCR Technologies, by Type USD Million (2021-2026)
  • Table 193. Argentina PCR Technologies, by Application USD Million (2021-2026)
  • Table 194. Argentina PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 195. Argentina PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 196. Rest of South America PCR Technologies, by Type USD Million (2021-2026)
  • Table 197. Rest of South America PCR Technologies, by Application USD Million (2021-2026)
  • Table 198. Rest of South America PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 199. Rest of South America PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 200. Asia Pacific PCR Technologies, by Country USD Million (2021-2026)
  • Table 201. Asia Pacific PCR Technologies, by Type USD Million (2021-2026)
  • Table 202. Asia Pacific PCR Technologies, by Application USD Million (2021-2026)
  • Table 203. Asia Pacific PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 204. Asia Pacific PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 205. China PCR Technologies, by Type USD Million (2021-2026)
  • Table 206. China PCR Technologies, by Application USD Million (2021-2026)
  • Table 207. China PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 208. China PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 209. Japan PCR Technologies, by Type USD Million (2021-2026)
  • Table 210. Japan PCR Technologies, by Application USD Million (2021-2026)
  • Table 211. Japan PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 212. Japan PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 213. India PCR Technologies, by Type USD Million (2021-2026)
  • Table 214. India PCR Technologies, by Application USD Million (2021-2026)
  • Table 215. India PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 216. India PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 217. South Korea PCR Technologies, by Type USD Million (2021-2026)
  • Table 218. South Korea PCR Technologies, by Application USD Million (2021-2026)
  • Table 219. South Korea PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 220. South Korea PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 221. Australia PCR Technologies, by Type USD Million (2021-2026)
  • Table 222. Australia PCR Technologies, by Application USD Million (2021-2026)
  • Table 223. Australia PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 224. Australia PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 225. Rest of Asia-Pacific PCR Technologies, by Type USD Million (2021-2026)
  • Table 226. Rest of Asia-Pacific PCR Technologies, by Application USD Million (2021-2026)
  • Table 227. Rest of Asia-Pacific PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 228. Rest of Asia-Pacific PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 229. Europe PCR Technologies, by Country USD Million (2021-2026)
  • Table 230. Europe PCR Technologies, by Type USD Million (2021-2026)
  • Table 231. Europe PCR Technologies, by Application USD Million (2021-2026)
  • Table 232. Europe PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 233. Europe PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 234. Germany PCR Technologies, by Type USD Million (2021-2026)
  • Table 235. Germany PCR Technologies, by Application USD Million (2021-2026)
  • Table 236. Germany PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 237. Germany PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 238. France PCR Technologies, by Type USD Million (2021-2026)
  • Table 239. France PCR Technologies, by Application USD Million (2021-2026)
  • Table 240. France PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 241. France PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 242. Italy PCR Technologies, by Type USD Million (2021-2026)
  • Table 243. Italy PCR Technologies, by Application USD Million (2021-2026)
  • Table 244. Italy PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 245. Italy PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 246. United Kingdom PCR Technologies, by Type USD Million (2021-2026)
  • Table 247. United Kingdom PCR Technologies, by Application USD Million (2021-2026)
  • Table 248. United Kingdom PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 249. United Kingdom PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 250. Netherlands PCR Technologies, by Type USD Million (2021-2026)
  • Table 251. Netherlands PCR Technologies, by Application USD Million (2021-2026)
  • Table 252. Netherlands PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 253. Netherlands PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 254. Rest of Europe PCR Technologies, by Type USD Million (2021-2026)
  • Table 255. Rest of Europe PCR Technologies, by Application USD Million (2021-2026)
  • Table 256. Rest of Europe PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 257. Rest of Europe PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 258. MEA PCR Technologies, by Country USD Million (2021-2026)
  • Table 259. MEA PCR Technologies, by Type USD Million (2021-2026)
  • Table 260. MEA PCR Technologies, by Application USD Million (2021-2026)
  • Table 261. MEA PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 262. MEA PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 263. Middle East PCR Technologies, by Type USD Million (2021-2026)
  • Table 264. Middle East PCR Technologies, by Application USD Million (2021-2026)
  • Table 265. Middle East PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 266. Middle East PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 267. Africa PCR Technologies, by Type USD Million (2021-2026)
  • Table 268. Africa PCR Technologies, by Application USD Million (2021-2026)
  • Table 269. Africa PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 270. Africa PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 271. North America PCR Technologies, by Country USD Million (2021-2026)
  • Table 272. North America PCR Technologies, by Type USD Million (2021-2026)
  • Table 273. North America PCR Technologies, by Application USD Million (2021-2026)
  • Table 274. North America PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 275. North America PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 276. United States PCR Technologies, by Type USD Million (2021-2026)
  • Table 277. United States PCR Technologies, by Application USD Million (2021-2026)
  • Table 278. United States PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 279. United States PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 280. Canada PCR Technologies, by Type USD Million (2021-2026)
  • Table 281. Canada PCR Technologies, by Application USD Million (2021-2026)
  • Table 282. Canada PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 283. Canada PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 284. Mexico PCR Technologies, by Type USD Million (2021-2026)
  • Table 285. Mexico PCR Technologies, by Application USD Million (2021-2026)
  • Table 286. Mexico PCR Technologies, by Technology Type Name USD Million (2021-2026)
  • Table 287. Mexico PCR Technologies, by End User Name USD Million (2021-2026)
  • Table 288. PCR Technologies: by Type(USD/Units)
  • Table 289. Research Programs/Design for This Report
  • Table 290. Key Data Information from Secondary Sources
  • Table 291. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global PCR Technologies: by Type USD Million (2015-2020)
  • Figure 5. Global PCR Technologies: by Application USD Million (2015-2020)
  • Figure 6. Global PCR Technologies: by Technology Type Name USD Million (2015-2020)
  • Figure 7. Global PCR Technologies: by End User Name USD Million (2015-2020)
  • Figure 8. South America PCR Technologies Share (%), by Country
  • Figure 9. Asia Pacific PCR Technologies Share (%), by Country
  • Figure 10. Europe PCR Technologies Share (%), by Country
  • Figure 11. MEA PCR Technologies Share (%), by Country
  • Figure 12. North America PCR Technologies Share (%), by Country
  • Figure 13. Global PCR Technologies: by Type USD/Units (2015-2020)
  • Figure 14. Global PCR Technologies share by Players 2020 (%)
  • Figure 15. Global PCR Technologies share by Players (Top 3) 2020(%)
  • Figure 16. Global PCR Technologies share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. F. Hoffman-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. F. Hoffman-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 22. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 25. QIAGEN N.V. (Germany) Revenue: by Geography 2020
  • Figure 26. Takara Bio, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Takara Bio, Inc. (Japan) Revenue: by Geography 2020
  • Figure 28. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. BioMérieux S.A. (France) Revenue, Net Income and Gross profit
  • Figure 31. BioMérieux S.A. (France) Revenue: by Geography 2020
  • Figure 32. Fluidigm Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Fluidigm Corporation (United States) Revenue: by Geography 2020
  • Figure 34. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 36. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 37. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 38. Global PCR Technologies: by Type USD Million (2021-2026)
  • Figure 39. Global PCR Technologies: by Application USD Million (2021-2026)
  • Figure 40. Global PCR Technologies: by Technology Type Name USD Million (2021-2026)
  • Figure 41. Global PCR Technologies: by End User Name USD Million (2021-2026)
  • Figure 42. South America PCR Technologies Share (%), by Country
  • Figure 43. Asia Pacific PCR Technologies Share (%), by Country
  • Figure 44. Europe PCR Technologies Share (%), by Country
  • Figure 45. MEA PCR Technologies Share (%), by Country
  • Figure 46. North America PCR Technologies Share (%), by Country
  • Figure 47. Global PCR Technologies: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Fisher Scientific, Inc. (United States)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Bio-Rad Laboratories, Inc. (United States)
  • QIAGEN N.V. (Germany)
  • Takara Bio, Inc. (Japan)
  • Agilent Technologies, Inc. (United States)
  • bioMérieux S.A. (France)
  • Fluidigm Corporation (United States)
  • Danaher Corporation (United States)
  • Abbott Laboratories (United States)
Additional players considered in the study are as follows:
Merck KGaA (Germany) , Becton Dickinson and Company (United States) , Promega Corporation (United States) , Eppendorf AG (Germany) , Analytik Jena AG (Germany)
Select User Access Type

Key Highlights of Report


Dec 2021 201 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) PCR Technologies Quantitative research analysis
Global (United States, European Union and China) PCR Technologies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The PCR Technologies study can be customized to meet your requirements. The market size breakdown by type [Instruments, Reagents and consumables and Software and services], by end use application [Genetic sequencing, Genotyping, Nucleic acid detection, Nucleic acid synthesis, Standard validation/verification, Diagnostic Applications, Industrial Applications and Other Applications].
The PCR Technologies Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global PCR Technologies market is expected to see growth rate of %.

Know More About Global (United States, European Union and China) PCR Technologies Report?

Have a Query? Click Here

Other Related Reports

Electromagnetic Radiation Protective Clothes Comprehensive Study by Application (Military, Medical, Research Institute, Others), Distribution Channel (Online, Offline), Gender (Male, Female), Shieldi...
$ 3450
Depyrogenated Sterile Empty Vials  Comprehensive Study by Type (2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml), Package Technology (Glass {Molded, Tubular}, Plastic), End User (Clinical Labs, Compounding...
$ 3450
Neuromodulation Comprehensive Study by Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity), Technology (Internal Neuromodulation, External Neuromodulation), End ...
$ 3650
Health Care Mobility Solutions Comprehensive Study by Type (Mobile Devices, Mobile Applications (Apps), Enterprise Mobility Platforms), Application (Enterprise Solutions {Patient Care Management, Ope...
$ 3650
Physician Practice Management Comprehensive Study by Application (Private Practice, Group Practice, Large Health Maintenance Organizations (HMOs), Others), Deployment Type (On-premise, Cloud-based, W...
$ 3750
e-Clinical Trial Technologies Comprehensive Study by Phase (Phase I, Phase II, Phase III, Phase IV), Electronics Solutions (Clinical Analytics Platforms, Electronic Data Capture (EDC), Clinical Data ...
$ 3750